Cardiologist with heart on screen_iStock_4366846Medium_5
Feature

March 31, 2014 — Led by members of the American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), 14 professional societies from across the world have developed a health policy statement that defines the clinical standards for structured reporting in the cardiac catheterization suite.

Home March 31, 2014
Home
Terumo Corp. Arterial Remodeling Technologies Bioresorbable Coronary Stent
Feature

Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo Corp. Under the agreement, ART and Terumo Corp. will collaborate in the development of a drug eluting bioresorbable scaffold or stent, intended for use in the treatment of coronary artery disease.

Home March 31, 2014
Home
News

eCardio Diagnostics will highlight its expertise for integrating its services with customers' existing electronic medical records (EMR) systems at upcoming conferences.

Home March 31, 2014
Home
Technology

St. Jude Medical Inc. announced the global launch of the Optisure defibrillation lead.

Home March 28, 2014
Home
News

At the 63rd Annual Scientific Session of the American College of Cardiology (ACC), March 29-31 at the Walter E. Washington Convention Center in Washington, D.C., Siemens Healthcare will deliver solutions for sustainable cardiovascular care to aid healthcare professionals

Home March 28, 2014
Home
News

Medtronic, Inc. announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients in developing countries at high risk for sudden cardiac arrest (SCA)–an abrupt loss of heart function that can lead to death in minutes–who have not previously experienced a life threatening arrhythmia (primary prevention patients). The first patients were enrolled at West China Hospital and Fuwai Hospital in China.

Home March 27, 2014
Home
News

Scientists at CBSET are reminding thought leaders in renal denervation that there is a seminal experimental and computational template for the more rational, comprehensive preclinical evaluation and optimization of renal denervation devices that can be utilized during preclinical and clinical development.

Home March 27, 2014
Home
News

Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla.

Home March 27, 2014
Home
Technology

The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for three new digital angiography systems from Shimadzu Medical Systems. These are the ceiling-mounted Trinias, the floor-mounted Trinias, and the Biplane models.

Home March 27, 2014
Home
News

Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Home March 26, 2014
Home
stent_with_cover_
Feature

InspireMD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European clinical trial for the new CGuard carotid embolic protection system.

Home March 26, 2014
Home
News

Based on its recent analysis of the superconductor technology for MRI market, Frost & Sullivan recognizes Cutting Edge Superconductors, Inc. with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership.

Home March 26, 2014
Home
Technology

St. Jude Medical Inc. has received approval from the U.S. Food and Drug Administration (FDA) for the Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure (HF). The company also announced FDA approvals for the Assurity pacemaker and Endurity pacemaker families of devices.

Home March 26, 2014
Home
News

Aerotel Medical Systems has received the CE Mark approval for its new electrocardiogram (ECG) devices, HeartView P12/8i and HeartView 12L.

Home March 25, 2014
Home
biotronik, MRI safe ICD
Feature

Biotronik has announced the Food and Drug Administration (FDA) has approved the expansion of Biotronik’s ongoing ProMRI clinical trial. The new phase of the trial (Phase C) will study the company’s ProMRI technology in implantable cardioverter-defibrillator (ICD) devices. Biotronik is the only company in the world with an ICD that is approved for investigational use in a magnetic resonance imaging (MRI) scanner. The ongoing ProMRI study is the first step in making this standalone technology available in the United States.

Home March 25, 2014
Home
Subscribe Now